Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Nature

• Publication date

  1990-11-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/348331A0PMID 2250704
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• BCL2-mediated tumorigenicity of a human T-lymphoid cell line: synergy with MYC and inhibition by BCL2 antisense.

  1990cited by this paper
• Deregulated Bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population

  1990cited by this paper
• Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines.

  1990cited by this paper
• Growth- and tumor-promoting effects of deregulated BCL2 in human B-lymphoblastoid cells.

  1989cited by this paper
• Activation of MYC in a masked t(8;17) translocation results in an aggressive B-cell leukemia.

  1989cited by this paper
• L3T4 antigen expression by hemopoietic precursor cells

  1989cited by this paper
• A bcr-v-abl oncogene induces lymphomas in transgenic mice

  1989cited by this paper
• The V(D)J recombination activating gene, RAG-1.

  1989cited by this paper
• Deregulated BCL2 expression enhances growth of a human B cell line.

  1989cited by this paper
• Stress-resistance conferred by high level of bcl-2 alpha protein in human B lymphoblastoid cell.

  1989cited by this paper
• bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation.

  1989cited by this paper
• The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation

  1989cited by this paper
• Growth of E mu-myc transgenic B-lymphoid cells in vitro and their evolution toward autonomy.

  1988cited by this paper
• PB76: a novel surface glycoprotein preferentially expressed on mouse pre‐B cells and plasma cells detected by the monoclonal antibody G‐52

  1988cited by this paper
• The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells

  1988cited by this paper
• Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

  1988cited by this paper
• Purification and characterization of mouse hematopoietic stem cells.

  1988cited by this paper
• Evolution of B-cell malignancy: pre-B-cell leukemia resulting from MYC activation in a B-cell neoplasm with a rearranged BCL2 gene.

  1988cited by this paper
• Transgenic mice bearing the human c-myc gene activated by an immunoglobulin enhancer: a pre-B-cell lymphoma model.

  1988cited by this paper
• Continuing rearrangement of immunoglobulin and T-cell receptor genes in a Ha-ras-transformed lymphoid progenitor cell line.

  1987cited by this paper
• Characterization of the protein product of bcl-2, the gene involved in human follicular lymphoma.

  1987cited by this paper
• Expression of the 6C3 antigen on murine hematopoietic neoplasms. Association with expression of abl, ras, fes, src, erbB, and Cas NS-1 oncogenes but not with myc

  1987cited by this paper
• Regulation of bcl-2 proto-oncogene expression during normal human lymphocyte proliferation.

  1987cited by this paper
• Expression of Bcl-2 and Bcl-2-Ig fusion transcripts in normal and neoplastic cells.

  1987cited by this paper
• Activation of cellular oncogenes in hemopoietic cells by chromosome translocation.

  1986cited by this paper
• Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation.

  1986cited by this paper
• An attempt to produce “pre‐T” cell hybridomas and to identify their antigens

  1986cited by this paper
• λ5, a new light-chain-related locus selectively expressed in pre-B lymphocytes

  1986cited by this paper
• The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice.

  1986cited by this paper
• Il-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo.

  1985cited by this paper
• Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18.

  1985cited by this paper
• The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice

  1985cited by this paper
• Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation.

  1984cited by this paper
• A 14;18 and an 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemia.

  1984cited by this paper
• Chromosome abnormalities in poorly differentiated lymphocytic lymphoma.

  1979cited by this paper

• What does BCL-2 do? From new molecular insights to the clinical implications.

  2026cites this paper
• Apoptosis in Cancer Biology and Therapy.

  2025cites this paper
• MNT: a new target for AML

  2025cites this paper
• Genome-wide in vivo CRISPR screens identify GATOR1 complex as a tumor suppressor in Myc-driven lymphoma

  2025cites this paper
• A novel 5’tRNA-derived fragment tRF-Tyr inhibits tumor progression by targeting hnRNPD in gastric cancer

  2025cites this paper
• The BCL-2 protein family: from discovery to drug development

  2025cites this paper
• From unearthing to an intriguing cancer-fighting target: the human BCL-2 promoter G-quadruplex and i-motif.

  2025cites this paper
• Unraveling the meta-hallmarks between senescent and tumor cells: A new perspective for senolytic drug discovery

  2025cites this paper
• The role of c-MYC in gastric cancer prognosis: a Kaplan-Meier-derived patient data meta-analysis

  2025cites this paper
• Unraveling the Role of Ras Homolog Enriched in Brain (Rheb1 and Rheb2): Bridging Neuronal Dynamics and Cancer Pathogenesis through Mechanistic Target of Rapamycin Signaling

  2024cites this paper
• New classifications of B-cell neoplasms: a comparison of 5th WHO and International Consensus classifications

  2024cites this paper
• EBNA2: a viral maestra conducting a symphony orchestra.

  2024cites this paper
• Disruption of the ZFP574–THAP12 complex suppresses B cell malignancies in mice

  2024cites this paper
• T-Lymphoblastic Lymphoma Cells Express High Levels of BCL2, S1P1, and ICAM1, Leading to a Blockade of Tumor Cell Intravasation.

  2024cites this paper
• Cell death.

  2024cites this paper
• Luminal breast epithelial cells from wildtype and BRCA mutation carriers harbor copy number alterations commonly associated with breast cancer

  2024cites this paper
• Increased c-MYC Expression Associated with Active IGH Locus Rearrangement: An Emerging Role for c-MYC in Chronic Lymphocytic Leukemia

  2024cites this paper
• A phase 1 study of the CDK9 inhibitor voruciclib in relapsed/refractory acute myeloid leukemia and B-cell malignancies

  2024cites this paper
• Lentivirus-Mediated BCL-XL Overexpression Inhibits Stem Cell Apoptosis during Ex Vivo Expansion and Provides Competitive Advantage Following Xenotransplantation

  2024cites this paper
• Luminal breast epithelial cells of BRCA1 or BRCA2 mutation carriers and noncarriers harbor common breast cancer copy number alterations

  2024cites this paper
• Cellular communication during apoptosis

  2024influential citation
• Don't fear the reaper: The role of regulated cell death in tumorigenesis and BH3-mimetics for cancer therapy.

  2024cites this paper
• Transcriptional-translational conflict is a barrier to cellular transformation and cancer progression.

  2023cites this paper
• Role of intrinsic apoptosis in environmental exposure health outcomes.

  2023cites this paper
• Apoptotic cell death in disease—Current understanding of the NCCD 2023

  2023cites this paper
• Study on Sgc8 Aptamer-mediated Nucleic Acid Nanomaterial-doxorubicin Complex for Tumor Targeted Therapy.

  2023cites this paper
• Demystifying the Druggability of the MYC Family of Oncogenes.

  2023cites this paper
• microRNA sequencing for biomarker detection in the diagnosis, classification and prognosis of Diffuse Large B Cell Lymphoma

  2023cites this paper
• Upregulation of XRCC1 DNA Repair Gene, Interleukin-8, and Bcl-2 Antiapoptotic Gene Levels in Kurdish Patients with Gastric Adenocarcinoma.

  2023cites this paper
• Targeting MYC-driven lymphoma: lessons learned and future directions

  2023cites this paper
• Mechanisms of BCL-2 family proteins in mitochondrial apoptosis

  2023cites this paper
• MNT suppresses T cell apoptosis via BIM and is critical for T lymphomagenesis

  2023cites this paper
• Erratum to Synergistic efficacy of homoharringtonine and venetoclax on acute myeloid leukemia cells and the underlying mechanisms

  2022cites this paper
• Deletion of the transcriptional regulator TFAP4 accelerates c-MYC-driven lymphomagenesis

  2022cites this paper
• Distinct B-Cell Specific Transcriptional Contexts of the BCL2 Oncogene Impact Pre-Malignant Development in Mouse Models

  2022cites this paper
• Generation of a CRISPR activation mouse that enables modelling of aggressive lymphoma and interrogation of venetoclax resistance

  2022cites this paper
• BCL-2 protein family: attractive targets for cancer therapy

  2022cites this paper
• Adapted to Survive: Targeting Cancer Cells with BH3 Mimetics

  2022cites this paper
• Novel benzo chromene derivatives: design, synthesis, molecular docking, cell cycle arrest, and apoptosis induction in human acute myeloid leukemia HL-60 cells

  2022cites this paper
• Persistent DNA damage and oncogenic stress-induced Trem1 promotes leukemia in mice

  2022cites this paper
• Impaired ribosome biogenesis checkpoint activation induces p53-dependent MCL-1 degradation and MYC-driven lymphoma death.

  2021cites this paper
• Genetic Analysis of Multiple Myeloma Identifies Cytogenetic Alterations Implicated in Disease Complexity and Progression

  2021cites this paper
• Targeting MYCN in Pediatric and Adult Cancers

  2021cites this paper
• Molecular Signaling to Preserve Mitochondrial Integrity against Ischemic Stress in the Heart: Rescue or Remove Mitochondria in Danger

  2021cites this paper
• Diverse B-cell specific transcriptional contexts of the BCL2 oncogene in mouse models impacts pre-malignant development

  2021cites this paper
• A novel CRISPR activation mouse enables modelling of aggressive lymphoma and interrogation of venetoclax resistance.

  2021cites this paper
• Curcumin arrests G-quadruplex in the nuclear hyper-sensitive III1 element of c-MYC oncogene leading to apoptosis in metastatic breast cancer cells

  2021cites this paper
• The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs

  2021cites this paper
• BH3 Mimetics in Hematologic Malignancies

  2021cites this paper
• IL-6 promotes MYC-induced B cell lymphomagenesis independent of STAT3

  2021cites this paper
• Assessing eukaryotic initiation factor 4F subunit essentiality by CRISPR-induced gene ablation in the mouse

  2021cites this paper
• Mouse Models of Germinal Center Derived B-Cell Lymphomas

  2021cites this paper
• Integrin‐Targeted, Short Interfering RNA Nanocomplexes for Neuroblastoma Tumor‐Specific Delivery Achieve MYCN Silencing with Improved Survival

  2021cites this paper
• Distinct roles for PARP-1 and PARP-2 in c-Myc-driven B-cell lymphoma in mice.

  2021cites this paper
• Inflammatory Cell Death, PANoptosis, Mediated by Cytokines in Diverse Cancer Lineages Inhibits Tumor Growth

  2021cites this paper
• in Diverse Cancer Lineages Inhibits Tumor Growth Inflammatory Cell Death, PANoptosis, Mediated by Cytokines

  2021cites this paper
• Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphoma

  2021cites this paper
• Co-Operativity between MYC and BCL-2 Pro-Survival Proteins in Cancer

  2021cites this paper
• Potential role of priming effect in the open ocean oxygen minimum zones: an outlook

  2021cites this paper
• Evasion of cell death: A contributory factor in prostate cancer development and treatment resistance.

  2021cites this paper
• The Program Cell Death (Apoptosis) and the Therapy of Cancer

  2021cites this paper
• PDCD4 regulates apoptosis in human peritoneal mesothelial cells and promotes gastric cancer peritoneal metastasis.

  2021cites this paper
• Physiological Functions of Mcl-1: Insights From Genetic Mouse Models

  2021cites this paper
• MicroRNA dysregulation and multi-targeted therapy for cancer treatment.

  2020cites this paper
• Therapeutic development and current uses of BCL-2 inhibition.

  2020cites this paper
• Cancer biology and other disorders: beneficial role of camptothecin and novel derivatives

  2020cites this paper
• BH3 Mimetics for the Treatment of B-Cell Malignancies—Insights and Lessons from the Clinic

  2020cites this paper
• Emerging connectivity of programmed cell death pathways and its physiological implications

  2020cites this paper
• Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review

  2020cites this paper
• Berberine Exerts Anti-cancer Activity by Modulating Adenosine Monophosphate-Activated Protein Kinase (AMPK) and the Phosphatidylinositol 3-Kinase/Protein Kinase B (PI3K/AKT) Signaling Pathways.

  2020cites this paper
• Estimation of Bcl-2 and Ki-67 in Gingival Epithelium of Epileptic Patients

  2020cites this paper
• Inhibiting the inhibitors: Targeting anti-apoptotic proteins in cancer and therapy resistance.

  2020cites this paper
• BCL-2 family deregulation in colorectal cancer: potential for BH3 mimetics in therapy

  2020cites this paper
• Toward Targeting Antiapoptotic MCL-1 for Cancer Therapy

  2020cites this paper
• Efficacy and molecular mechanisms of the BH3-mimetic venetoclax (ABT-199) in pediatric acute lymphoblastic leukemia

  2020cites this paper
• Cell Death in the Origin and Treatment of Cancer.

  2020cites this paper
• Development and Survival of MYC-driven Lymphomas Requires MYC-Antagonist MNT to Curb MYC-induced Apoptosis.

  2020cites this paper
• Cell Death Pathways in Lymphoid Malignancies

  2020cites this paper
• Medicinal plants: active compounds, properties and antiproliferative effects in colorectal cancer

  2020cites this paper
• A BAG's life: Every connection matters in cancer.

  2020cites this paper
• Venetoclax in the Treatment of Chronic Lymphocytic Leukemia: Evidence, Expectations, and Future Prospects

  2020cites this paper
• 5-Azacitidine Induces NOXA to Prime AML Cells for Venetoclax-Mediated Apoptosis

  2020cites this paper
• Exploiting Necroptosis for Therapy of Acute Lymphoblastic Leukemia

  2019cites this paper
• MYC in Germinal Center‐derived lymphomas: Mechanisms and therapeutic opportunities

  2019cites this paper
• EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins

  2019cites this paper
• 1-1-2019 Targeting the Bcl-2 Family in B Cell Lymphoma

  2019influential citation
• B Cell Lymphomagenesis

  2019cites this paper
• Generation and Modeling of Radiation for Clinical and Research Applications

  2019cites this paper
• The second genome: Effects of the mitochondrial genome on cancer progression.

  2019cites this paper
• The Functional Role of Bcl-2 Family of Proteins in the Immune System and Cancer

  2019cites this paper
• Zebrafish modelling of apoptosis and inflammation in aggressive B-cell lymphoma

  2019cites this paper
• Achievement in cancer research and its therapeutics in hundred years.

  2019cites this paper
• Meeting the Challenge of Targeting Cancer Stem Cells

  2019cites this paper
• Reactive Oxygen Species in Plasma Medical Science (PAM and Cancer Therapy)

  2019cites this paper
• Targeting the Bcl-2 Family in B Cell Lymphoma

  2019influential citation
• Unmasking the Mysteries of MYC

  2019influential citation
• Venetoclax for the treatment of mantle cell lymphoma

  2019cites this paper
• Cyclin-Dependent Kinase-9 Is a Therapeutic Target in MYC-Expressing Diffuse Large B-Cell Lymphoma

  2019cites this paper
• The evolving role of translocation t(11;14) in the biology, prognosis, and management of multiple myeloma.

  2019cites this paper
• Targeting Apoptotic Pathways in Acute Myeloid Leukaemia

  2019cites this paper